Showing 41 - 57 results of 57 for search 'Medicare (United States)', query time: 0.06s Refine Results
  1. 41

    System Dynamics Modeling Can be Leveraged to Predict Critical Care Pathways and Costs for End Stage Renal Disease: US Population to 2020 by Luca Fernandez, Christopher Koliba, Asim Zia, Katharine Cheung, Richard Solomon, Christopher Jones

    Published 2015-07-01
    “…**Methods:** A system dynamics model was designed to project the prevalence and total costs of ESRD treatment for the United States through 2020. Incidence, transplant and mortality rates were modeled for 35 age and primary diagnosis subgroups coursing through different ESRD critical care pathways. …”
    Get full text
    Article
  2. 42

    Mitral Valve Transcatheter Edge-to-Edge Repair Volumes and Trends by Kris Kumar, Timothy F. Simpson, Harsh Golwala, Adnan K. Chhatriwalla, Scott M. Chadderdon, Robert L. Smith, Howard K. Song, Ryan R. Reeves, Paul Sorajja, Firas E. Zahr

    Published 2023-01-01
    “…We aimed to identify annual operator procedural volumes, temporal trends, and geographic variability for MTEER among Medicare patients in the United States (US). Methods. …”
    Get full text
    Article
  3. 43
  4. 44
  5. 45

    Enhancing healthcare cost transparency: assessing implementation challenges, criticisms, and alternative solutions by Sonia Ali Malik

    Published 2025-01-01
    “…The United States healthcare system grapples with a staggering estimated waste of $935 billion, with pricing failure contributing a substantial $240.5 billion. …”
    Get full text
    Article
  6. 46

    Bayesian hierarchical network autocorrelation models for estimating direct and indirect effects of peer hospitals on outcomes of hospitalized patients by Guanqing Chen, A. James O’Malley

    Published 2024-06-01
    “…A Bayesian approach is used for model estimation while a simulation study assesses the performance of the models and sensitivity of results to different prior distributions. We construct a United States New England region patient-sharing hospital network and apply newly developed Bayesian hierarchical models to study the diffusion of robotic surgery and hospital peer effects in patient outcomes using a cohort of United States Medicare beneficiaries in 2016 and 2017. …”
    Get full text
    Article
  7. 47

    Payment models and the sustainability of community pharmacy practice: a qualitative interview study with community pharmacists by Kelly Ann Schmidtke, Terri Warholak

    Published 2025-12-01
    “…Background The sustainability of community pharmacies in the United States depends, in large part, on policies enacted by the Centers for Medicare and Medicaid Services (CMS). …”
    Get full text
    Article
  8. 48
  9. 49

    An Automated Clinical Laboratory Decision Support System for Test Utilization, Medical Necessity Verification, and Payment Processing by Safedin Beqaj, Rojeet Shrestha, Tim Hamill

    Published 2025-02-01
    “…It has been well established and widely recognized that (1) laboratory testing provides 70%-85% of the objective data that physicians use in the diagnosis and treatment of their patients; (2) orders for laboratory tests in the United States have increased, with an estimated volume of 4-5 billion tests per year; (3) there is a lack of user-friendly tools to guide physicians in their test selection and ordering; and (4) laboratory test overutilization and underutilization continue to represent a pervasive source of inefficiency in the health care system. …”
    Get full text
    Article
  10. 50

    Competing Risks Analysis of Cancer-associated Recurrent Thrombosis, Major Bleeds, and Death in a Geriatric Cohort by Joshua D. Brown, Kelley L. Ratermann, Kelley L. Ratermann, Jeffery C. Talbert, Jeffery C. Talbert, Val R. Adams, Val R. Adams

    Published 2015-12-01
    “…These results are consistent with United States guidelines which recommend LMWHs over warfarin for treatment and secondary prevention of VTE.…”
    Get full text
    Article
  11. 51

    Effectiveness of a Patient Support Program in Supporting Access to Therapy for Solid Tumor Malignancies by Lindsay Parker, Alissa Shaul, Brian Murphy, Zeba M. Khan

    Published 2016-10-01
    “…**Objective:** To better understand the effect of patient support programs on access to therapy for solid tumor malignancies, this study evaluated service use, case outcomes, and patient characteristics from a manufacturer-sponsored program in the United States. **Methods:** Sociodemographic characteristics, services use rates, and outcomes by case and insurance type were evaluated at the patient- and case-level in a random sample of patients prescribed nab-paclitaxel for solid tumor malignancies who enrolled in the Celgene Patient Support (CPS) program (April 2011–November 2013). …”
    Get full text
    Article
  12. 52
  13. 53

    Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer by Franklin D. Gaylis, Bruno Emond, Ameur M. Manceur, Anabelle Tardif-Samson, Laura Morrison, Dominic Pilon, Patrick Lefebvre, Lorie A. Ellis, Hiremagalur Balaji, Andrea Ireland

    Published 2024-10-01
    “…**Objectives:** This study evaluated the adequacy of first-line intravesical BCG treatment among high-risk NMIBC patients in the United States, including the subgroup with carcinoma in situ (CIS) of the bladder. …”
    Get full text
    Article
  14. 54

    Validation of Mortality Data Sources Compared to the National Death Index in the Healthcare Integrated Research Database by Jamal-Allial A, Sponholtz T, Vojjala SK, Paullin M, Papazian A, Eshete B, Mahmoudpour SH, Verpillat P, Beachler DC

    Published 2025-02-01
    “…Aziza Jamal-Allial,1 Todd Sponholtz,1 Shiva K Vojjala,2 Mark Paullin,2 Anahit Papazian,1 Biruk Eshete,2 Seyed Hamidreza Mahmoudpour,3 Patrice Verpillat,3 Daniel C Beachler2 1Safety & Epidemiology, Carelon Research, Newton, MA, USA; 2Safety & Epidemiology, Carelon Research, Wilmington, DE, USA; 3Merck Healthcare KGaA, Darmstadt, GermanyCorrespondence: Daniel C Beachler, Carelon Research, 123 Justison Street, Suite 200, Wilmington, DE, 19801, USA, Email Daniel.beachler@carelon.comBackground: The National Death Index (NDI) is the gold standard for mortality data in the United States (US) but has a time lag and can be operationally intensive. …”
    Get full text
    Article
  15. 55

    Outcomes following intradetrusor onabotulinumtoxinA in a national cohort of nursing home residents by Leo D. Dreyfuss, Farnoosh Nik‐Ahd, Lufan Wang, Abigail Shatkin‐Margolis, Kenneth Covinsky, W. John Boscardin, Anne M. Suskind

    Published 2025-01-01
    “…Abstract Objectives To determine predictors of treatment success and complications following intradetrusor onabotulinumtoxinA injections among a large cohort of nursing home (NH) residents, representing one of the most frail and vulnerable populations in the United States. Materials and methods This is a retrospective cohort study of long‐stay NH residents who underwent onabotulinumtoxinA injections between 2014 and 2016. …”
    Get full text
    Article
  16. 56

    Feasibility, Usability, and Pilot Efficacy Study of a Software-Enabled, Virtual Pulmonary Rehabilitation with Remote Therapeutic Monitoring by Flynn S, Mosher CL, Cornelison S, Rao E, Metzler KA, Pu W, Davies J, Paladenech C, Doyle D, MacIntyre N, Ohar J

    Published 2025-01-01
    “…Sheryl Flynn,1 Christopher L Mosher,2,3 Sharon Cornelison,4 Erica Rao,2 Kimberly A Metzler,4 William Pu,1 John Davies,2 Connie Paladenech,4 Daniel Doyle,3 Neil MacIntyre,2 Jill Ohar5 1Blue Marble Health, Altadena, California, USA; 2Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University School of Medicine, Durham, North Carolina, USA; 3Duke Clinical Research Institute, Durham, North Carolina, United States; 3Cabin Creek Health Systems, Dawes, West Virginia, USA; 4Department of Cardiac and Pulmonary Rehabilitation, J. …”
    Get full text
    Article
  17. 57

    Comparative Ethics of Modern Payment Models by Jacob Riegler

    Published 2023-01-01
    “…The argument that incentives should not exist in healthcare because they foster competition and, therefore, cause disparities is acknowledged.[7] However, the argument against incentives ignores the reality of healthcare, especially in the United States, where the most progressive recommendations still retain a paying agency. …”
    Get full text
    Article